[1]
Z. . Mahdi and Z. D. . Kammas, “Network Pharmacology Analysis Predicts that Borago Officinalis Constituents May Influence STING/TBK1/IRF3 Immune Signalling in Non-Small Cell Lung Cancer”, Am. J. Med. Health Care., vol. 1, no. 2, pp. 105–111, Oct. 2026, doi: 10.54536/ajmhc.v1i2.6726.